-
The treatment is proving to be an effective tool at preventing severe illness, but patients who test positive for COVID-19 have to get it early in order for it to work well.
-
The FDA approves new prescribing instructions for Aduhelm to address confusion over who should get the drug, saying it is appropriate for patients with early or mild Alzheimer’s.
-
Moderna will ask the Food and Drug Administration to authorize its vaccine for kids from age 12 to 17 in early June, the company's CEO says.
-
Pfizer said in late March that clinical trials found "100% efficacy and robust antibody responses" to the coronavirus in 12- to 15-year-olds.
-
FDA action could lead to the two-dose shots being available for younger teens before the beginning of the next school year.
-
The four FEMA sites - including Tampa Greyhound Track - will have the capacity to administer up to 3,000 doses per day, the Florida Division of Emergency Management said.
-
The advisory committee's emergency meeting comes as the CDC is investigating the death of an Oregon woman and hospitalization of another in Texas after they received the vaccine.
-
The Food and Drug Administration greenlights the biotech firm's vaccine for emergency use in the U.S. The move bolsters a vast inoculation effort that's already underway.
-
Advisers to the Food and Drug Administration voted 20-0 to recommend that the agency authorize Moderna's vaccine for emergency use during the pandemic. There was a single abstention.
-
The drug is a combo of two antibodies to enhance the chances it will prove effective. It's an experimental medicine that President Trump was given when he was sickened last month.
-
The agency announced approval for the diagnostic method on Saturday. Cheaper and easier to administer than genetic tests for the virus, it could potentially expand to daily testing of millions.
-
Regional blood donation center OneBlood will begin collecting plasma from COVID-19 survivors as a possible treatment for future patients.An experimental…